Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
256.53B | 274.39B | 222.43B | 210.81B | 133.82B | 91.31B | Gross Profit |
71.92B | 73.36B | 69.86B | 72.08B | 48.68B | 30.78B | EBIT |
23.64B | 24.09B | 24.87B | 35.04B | 22.60B | 9.64B | EBITDA |
41.28B | 51.63B | 44.59B | 47.85B | 30.76B | 18.82B | Net Income Common Stockholders |
14.30B | 15.69B | 15.15B | 29.70B | 26.66B | 8.28B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
114.56B | 117.73B | 117.25B | 103.11B | 52.58B | 30.20B | Total Assets |
565.74B | 600.59B | 510.03B | 410.65B | 264.77B | 177.19B | Total Debt |
159.41B | 168.28B | 140.85B | 72.26B | 39.52B | 49.77B | Net Debt |
44.84B | 50.55B | 44.04B | -30.85B | -13.06B | 19.57B | Total Liabilities |
268.36B | 277.04B | 231.86B | 161.00B | 103.82B | 98.95B | Stockholders Equity |
216.19B | 236.83B | 204.41B | 183.77B | 131.07B | 67.18B |
Cash Flow | Free Cash Flow | ||||
0.00 | -25.17B | -46.51B | -13.95B | -15.99B | -1.08B | Operating Cash Flow |
0.00 | 26.07B | 28.72B | 43.02B | 17.83B | 13.22B | Investing Cash Flow |
0.00 | -36.63B | -92.40B | -68.76B | -29.40B | -20.88B | Financing Cash Flow |
0.00 | 15.97B | 55.24B | 68.72B | 30.60B | 21.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥79.07B | 8.41 | 1.17% | 11.53% | 20.33% | ||
80 Outperform | ¥125.60B | 7.99 | 7.01% | 6.14% | 23.36% | 3.63% | |
78 Outperform | ¥145.23B | 11.17 | 3.21% | 9.70% | -21.39% | ||
72 Outperform | ¥141.05B | 14.58 | 3.96% | 18.61% | 30.56% | ||
69 Neutral | ¥188.32B | 3.86 | 0.38% | -48.30% | ― | ||
62 Neutral | $11.93B | 10.60 | -7.51% | 3.00% | 7.40% | -8.09% |